Lab
Allina Health System
Allina Health System was paid $1.10M by Medicaid between Jan 2018 and Nov 2024, across 83 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 55% of everything it billed.
33Billing provider infoALLINA HEALTH SYSTEM
MINNEAPOLIS, MN 55407
MINNEAPOLIS, MN 55407
33aNPI1699718775assigned 06/14/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.10M
24GClaims44,117
24DCodes billed83
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Minnesota
Rank by total paid#19 of 69
Median peer was paid$48K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TALLARICO, DOMINICA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,339 | $48K | |
| 2019 | 7,422 | $122K | |
| 2020 | 14,040 | $640K | |
| 2021 | 1,862 | $37K | |
| 2022 | 2,176 | $51K | |
| 2023 | 11,225 | $179K | |
| 2024incomplete | 1,053 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 55% | 11,880 | 11,557 | $603K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.1% | 2,411 | 2,199 | $100K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.7% | 1,313 | 1,254 | $52K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.0% | 1,300 | 1,241 | $44K |
| 80061 | Lipid panel | 3.9% | 3,034 | 2,960 | $43K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.7% | 1,531 | 1,503 | $29K |
| 36415 | Collection of venous blood by venipuncture | 2.7% | 3,111 | 2,302 | $29K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.5% | 1,367 | 1,334 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 2,676 | 2,577 | $25K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.1% | 2,205 | 1,907 | $23K |
| 80053 | Comprehensive metabolic panel | 2.0% | 1,279 | 1,123 | $21K |
| 86803 | 1.2% | 1,085 | 1,065 | $14K |
71 more codes
| 83655 | <1% | 1,081 | $10K | |
| 87081 | <1% | 1,054 | $8K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,407 | $7K |
| 86003 | <1% | 338 | $7K | |
| 82607 | <1% | 465 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 583 | $5K |
| 84439 | <1% | 448 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 844 | $4K |
| 87340 | <1% | 288 | $3K | |
| 86360 | <1% | 85 | $3K | |
| 86359 | <1% | 85 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 52 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 433 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 328 | $2K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 115 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 118 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 30 | $1K |
| 87480 | <1% | 92 | $1K | |
| 87077 | <1% | 92 | $1K | |
| 85610 | <1% | 348 | $1K | |
| 84403 | <1% | 47 | $947.97 | |
| 87536 | <1% | 26 | $943.79 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 32 | $941.47 |
| 82390 | <1% | 36 | $928.04 | |
| 82565 | <1% | 125 | $846.04 | |
| 85027 | <1% | 249 | $821.23 | |
| 86705 | <1% | 57 | $781.73 | |
| 86709 | <1% | 56 | $710.65 | |
| 83721 | <1% | 121 | $697.60 | |
| 86708 | <1% | 43 | $532.43 | |
| 82728 | <1% | 64 | $521.73 | |
| 84146 | <1% | 36 | $507.51 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 24 | $493.88 |
| 87660 | <1% | 92 | $471.19 | |
| 87510 | <1% | 92 | $471.19 | |
| 87186 | <1% | 167 | $444.31 | |
| 84630 | <1% | 75 | $422.87 | |
| 82525 | <1% | 50 | $418.98 | |
| 87070 | <1% | 30 | $403.70 | |
| 83001 | <1% | 27 | $359.02 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 41 | $342.09 |
| 82043 | <1% | 60 | $338.74 | |
| 86682 | <1% | 13 | $337.87 | |
| 80076 | <1% | 46 | $256.45 | |
| 81015 | <1% | 105 | $237.01 | |
| 81001 | <1% | 137 | $236.90 | |
| 84311 | <1% | 34 | $228.86 | |
| 83540 | <1% | 49 | $208.97 | |
| 86780 | <1% | 26 | $206.09 | |
| 84480 | <1% | 13 | $185.17 | |
| 83088 | <1% | 15 | $182.15 | |
| 83550 | <1% | 32 | $173.86 | |
| 82085 | <1% | 13 | $163.29 | |
| 87338 | <1% | 12 | $149.92 | |
| 82248 | <1% | 102 | $129.15 | |
| 86140 | <1% | 27 | $112.15 | |
| 83970 | <1% | 13 | $111.87 | |
| 85018 | <1% | 105 | $104.73 | |
| 84460 | <1% | 86 | $90.39 | |
| 87075 | <1% | 17 | $85.25 | |
| 82746 | <1% | 12 | $60.44 | |
| 87210 | <1% | 16 | $59.30 | |
| 87102 | <1% | 17 | $55.02 | |
| 84450 | <1% | 36 | $42.03 | |
| 87205 | <1% | 17 | $38.88 | |
| 85652 | <1% | 54 | $26.64 | |
| 84132 | <1% | 18 | $25.05 | |
| 87088 | <1% | 14 | $23.59 | |
| 83735 | <1% | 13 | $19.73 | |
| 81003 | <1% | 33 | $19.39 | |
| 81025 | <1% | 14 | $17.22 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALLARICO, DOMINICA (COO)
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Coon Rapids, MN | $22.13M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | St Paul, MN | $10.77M |
| Allina Health System | Faribault, MN | $7.56M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Woodbury, MN | $5.49M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Hastings, MN | $4.22M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.